Search research articles
Contact Us
Filters
Showing results (71-80 of 79) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 79 results.
The Journal of General Virology
|
October 24, 2003
Long-term survival of New Zealand rabbit haemorrhagic disease virus RNA in wild rabbits, revealed by RT-PCR and phylogenetic analysis
N L Forrester, B Boag, S R Moss, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 8, 2000
A role for radiotherapy in neuropathic bone pain: preliminary response rates from a prospective trial (Trans-tasman radiation oncology group, TROG 96.05)
D E Roos, P C O'Brien, J G Smith, et al.
Australasian Radiology
|
September 7, 2000
Eligibility audits for the randomized neuropathic bone pain trial (TROG 96.05)
D E Roos, S R Davis, P C O'Brien, et al.
Applied and Environmental Microbiology
|
July 6, 2000
The common nodulation genes of Astragalus sinicus rhizobia are conserved despite chromosomal diversity
X X Zhang, S L Turner, X W Guo, et al.
The Journal of General Virology
|
September 19, 2002
Molecular epidemiology of Rabbit haemorrhagic disease virus
S R Moss, S L Turner, R C Trout, et al.
Journal of Virology
|
December 13, 2002
Characterization of a siberian virus isolated from a patient with progressive chronic tick-borne encephalitis
T S Gritsun, T V Frolova, A I Zhankov, et al.
Virology
|
November 18, 2005
Phylogenetic analysis of rabbit haemorrhagic disease virus strains from the Arabian Peninsula: did RHDV emerge simultaneously in Europe and Asia?
N L Forrester, M I Abubakr, E M E Abu Elzein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 15, 2000
Phase I clinical and pharmacokinetic study of oral S-1 in patients with advanced solid tumors
C J van Groeningen, G J Peters, J H Schornagel, et al.
Cancer Chemotherapy and Pharmacology
|
May 10, 2003
Pharmacokinetics of S-1, an oral formulation of ftorafur, oxonic acid and 5-chloro-2,4-dihydroxypyridine (molar ratio 1:0.4:1) in patients with solid tumors
G J Peters, P Noordhuis, A B P Van Kuilenburg, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 79) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 79 results.
The Journal of General Virology
|
October 24, 2003
Long-term survival of New Zealand rabbit haemorrhagic disease virus RNA in wild rabbits, revealed by RT-PCR and phylogenetic analysis
N L Forrester, B Boag, S R Moss, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 8, 2000
A role for radiotherapy in neuropathic bone pain: preliminary response rates from a prospective trial (Trans-tasman radiation oncology group, TROG 96.05)
D E Roos, P C O'Brien, J G Smith, et al.
Australasian Radiology
|
September 7, 2000
Eligibility audits for the randomized neuropathic bone pain trial (TROG 96.05)
D E Roos, S R Davis, P C O'Brien, et al.
Applied and Environmental Microbiology
|
July 6, 2000
The common nodulation genes of Astragalus sinicus rhizobia are conserved despite chromosomal diversity
X X Zhang, S L Turner, X W Guo, et al.
The Journal of General Virology
|
September 19, 2002
Molecular epidemiology of Rabbit haemorrhagic disease virus
S R Moss, S L Turner, R C Trout, et al.
Journal of Virology
|
December 13, 2002
Characterization of a siberian virus isolated from a patient with progressive chronic tick-borne encephalitis
T S Gritsun, T V Frolova, A I Zhankov, et al.
Virology
|
November 18, 2005
Phylogenetic analysis of rabbit haemorrhagic disease virus strains from the Arabian Peninsula: did RHDV emerge simultaneously in Europe and Asia?
N L Forrester, M I Abubakr, E M E Abu Elzein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 15, 2000
Phase I clinical and pharmacokinetic study of oral S-1 in patients with advanced solid tumors
C J van Groeningen, G J Peters, J H Schornagel, et al.
Cancer Chemotherapy and Pharmacology
|
May 10, 2003
Pharmacokinetics of S-1, an oral formulation of ftorafur, oxonic acid and 5-chloro-2,4-dihydroxypyridine (molar ratio 1:0.4:1) in patients with solid tumors
G J Peters, P Noordhuis, A B P Van Kuilenburg, et al.
Page
of 8